4-Chloro-6,7-Dimethoxyquinazolin-4-amine

4-Chloro-6,7-Dimethoxyquinazolin-4-amine

CAS No. 183322-18-1

Pharmaceutical intermediate — Pharmaceutical intermediate for Active Pharmaceutical Ingredient (A... (CAS 183322-18-1)

4-Chloro-6,7-Dimethoxyquinazolin-4-amine is a high-purity pharmaceutical intermediate extensively used in the synthesis of quinazoline-based active pharmaceutical ingredients (APIs). It is an important building block for kinase inhibitors and anticancer drug development, including compounds such as Gefitinib and Erlotinib. Manufactured under stringent quality standards, this intermediate offers excellent purity, stability, and batch-to-batch consistency. Bulk quantities are available with COA and MSDS for pharmaceutical, research, and industrial applications.

Enquire About This Product
CAS Number183322-18-1
Molecular FormulaC10H10ClN3O2
Molecular Weight239.66 g/mol
Purity / Assay≥99.0% (HPLC)
AppearanceWhite to Light Yellow Crystalline Powder
Packaging1 Kg / 5 Kg / 25 Kg HDPE Drums
Storage ConditionsStore in a cool, dry, well-ventilated place. Keep the container tightly closed. Protect from moisture and direct sunlight.
HS Code29339990

Product Description

4-Chloro-6,7-Dimethoxyquinazolin-4-amine is a pharmaceutical intermediate manufactured and supplied by Swapnroop Research Private Limited (SRPL) (CAS No. 183322-18-1; molecular formula C10H10ClN3O2; a molecular weight of 239.66 g/mol). It is offered for research, development, and industrial manufacturing use.

It is supplied as a white to light yellow crystalline powder. Reference purity: ≥99.0% (HPLC). Available packaging: 1 Kg / 5 Kg / 25 Kg HDPE Drums. Recommended storage: store in a cool, dry, well-ventilated place. keep the container tightly closed. protect from moisture and direct sunlight..

Its principal application is pharmaceutical intermediate for Active Pharmaceutical Ingredient (API) synthesis. Key intermediate in the manufacture of quinazoline-based anticancer APIs. Used in the synthesis of Gefitinib, Erlotinib, Vandetanib, and related kinase inhibitor compounds. Suitable for medicinal chemistry, pharmaceutical R&D, and process development. Used in custom synthesis, fine chemical manufacturing, and research laboratories. Ideal for analytical standards and pharmaceutical process optimization., supporting downstream API synthesis, medicinal chemistry research, and process development carried out by pharmaceutical and specialty chemical manufacturers.

SRPL manufactures and sources this product under a quality-controlled process and can supply it in laboratory (gram/kilogram) to bulk quantities. A Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) are available on request. For current lead time, packaging options, and pricing, please contact our technical sales team at sales@srpl.ai or +91 8237049500.

Applications

Pharmaceutical intermediate for Active Pharmaceutical Ingredient (API) synthesis. Key intermediate in the manufacture of quinazoline-based anticancer APIs. Used in the synthesis of Gefitinib, Erlotinib, Vandetanib, and related kinase inhibitor compounds. Suitable for medicinal chemistry, pharmaceutical R&D, and process development. Used in custom synthesis, fine chemical manufacturing, and research laboratories. Ideal for analytical standards and pharmaceutical process optimization.

Why Choose SRPL